Q1 2019 Orexo AB Earnings Call Transcript
Ladies and gentlemen, welcome to the Orexo AB audio conference -- teleconference Q1 2019 call. Today, I'm pleased to present Nikolaj Sørensen, Chief Executive Officer and Joseph DeFeo, Chief Financial Officer. (Operator Instructions) Speakers, please begin.
¸ - ()-&
Thank you very much, and welcome to this first quarter call for Orexo in 2019. If I look back on the quarter we have just been through, it has been a very strong start of 2019. Leading a pharmaceutical company, I think the main topic is do you want to show good sales growth and we have shown good sales growth, in particular in Swedish krona, but also in local currency. It's about profitability. We have improved our profitability substantially coming from the U.S. business and even on the corporate level despite having a significant cost for [leading] in this quarter. It's about developing a pipeline. And while we know there's a risk in the pipeline as some projects does not progress exactly
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsâ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |